Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arts, Society & Me.
Press releases published on March 26, 2025

Absci to Participate in Upcoming Investor Conferences
VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. H.C. …

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025
DURHAM, N.C., March 26, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the …

E-Star BioTech Announces Presentation During 2025 Annual Meeting of the American College of Cardiology
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney diseases, today announced its presentation of clinical trial …

Chargel Announces 2025 Athlete Roster
Irvine, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Chargel, a one-of-a-kind, thirst-quenching snack that delivers fast-acting energy and B vitamins, is delighted to announce its 2025 athlete partners: Taylor Spivey, Mota Alhouni, Chloe Spreen, and Chase …

LifeSci Communications Prepares for Growth with Five Leadership Appointments and Promotions
Ian Stone joins as president, Duc Le joins as EVP, head of digital, and Michael Moncayo joins as SVP, finance and operations Drew Levinson promoted to chief client officer, Jonathan Pappas promoted to SVP, head of media relations NEW YORK, March 26, 2025 ( …

Starton Therapeutics to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2025
PARAMUS, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today that the Company …

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 24th Annual …

LiveOne's (NASDAQ: LVO) Reaches Milestone 1.4 Million Subscribers and Ad-Supported Users
LOS ANGELES, March 26, 2025 (GLOBE NEWSWIRE) -- LiveOne (NASDAQ: LVO), an award-winning, creator-first, music, entertainment, and technology platform, announced today that it has exceeded 1.4 million subscribers and ad-supported users, fueled by its Tesla …

HydroGraph Announces April Investor Relations and Conference Schedule
TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (FRA: M98) (the "Company" or "HydroGraph"), a sustainable commercial manufacturer of pristine graphene, today announced that it will participate in a webcasted …

Saudi National Pavilion at London Design Biennale 2025: "Good Water" Invites Us to Rethink Our Relationship With Water
RIYADH, Saudi Arabia, March 26, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia returns to the London Design Biennale 2025 with an exhibition entitled Good Water, from 5–29 June 2025 at Somerset House. Commissioned by Saudi Arabia’s Architecture and Design …

Saudi National Pavilion at London Design Biennale 2025: "Good Water" Invites us to Rethink Our Relationship With Water
The exhibition is conceived by the multidisciplinary design collective including Alaa Tarabzouni, Aziz Jamal, Dur Kattan and Fahad bin Naif, whose design approach questions, disrupts, and reimagines systems of access and distribution of water and our …

Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
Event to highlight the differentiated features of Traws oral small molecule product candidates: Tivoxavir Marboxil, a single dose, CAP-dependent endonuclease inhibitor for Bird Flu Ratutrelvir, a main protease inhibitor, to be used without ritonavir, for …

Digi Power X to Announce 2024 Year End Financial Results on March 31st
MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data centers, plans to announce its financial results for the …

Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting
– Oral presentation to highlight preclinical data further supporting combination of KO-2806 with TKIs in ccRCC – – Company expects to present data from the Phase 1 FIT-001 trial evaluating KO-2806 and cabozantinib in patients with RCC in 2H 2025 – SAN …

Mineral Wool Market Size to Reach a Value of US$ 23.07 Billion by 2031, Exclusive Report by The Insight Partners
US …

Taboola Announces Q1 2025 Tracking to High End of Guidance Ranges Across All Key Metrics
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced that its first quarter 2025 results are tracking toward the high end of the previously disclosed …

Nominations Announced for the 2025 Canadian Screen Awards
Law & Order Toronto: Criminal Intent leads television nominations with 20; Universal Language | Une langue universelle tops film with 13 TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- The Academy of Canadian Cinema …

Dévoilement des finalistes des prix Écrans canadiens 2025
Law & Order Toronto: Criminal Intent mène en télévision avec 20 nominations; Une langue universelle est en tête dans le secteur du cinéma avec 13 nominations TORONTO, 26 mars 2025 (GLOBE NEWSWIRE) -- L’Académie canadienne du cinéma et de la télévision (l’ …

Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
Additional data from the MDNA11 ABILITY-1 trial to be presented at the Annual Meeting Pre-clinical data on Medicenna’s first-in-class Masked and Tumor Targeted Bifunctional anti-PD1-IL2 Superkine, MDNA113, will also be presented TORONTO and HOUSTON, March …

Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe
ADOPT Study Findings Highlight Nanox.AI’s Role in Enhancing Fracture Detection and Healthcare Cost Savings PETACH TIKVA, Israel, March 26, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging …